XML 40 R10.htm IDEA: XBRL DOCUMENT
v3.20.2

Investments | 9 Months Ended
--- | ---
May 31, 2020
Investments [Abstract] |
Investments | Investments
| May 31, 2020 |  | August 31, 2019
| (Dollars in thousands)
Equity method investments: |  |  |
CF Industries Nitrogen, LLC | $ | 2,724,668 |  |  | $ | 2,708,942 |
Ventura Foods, LLC | 364,726 |  |  | 374,516 |
Ardent Mills, LLC | 206,476 |  |  | 209,027 |
Other equity method investments | 247,778 |  |  | 267,247 |
Other investments | 123,311 |  |  | 124,264 |
Total investments | $ | 3,666,959 |  |  | $ | 3,683,996 |
Equity Method Investments Joint ventures and other investments, in which we have significant ownership and influence but not control, are accounted for in our condensed consolidated financial statements using the equity method of accounting. Our primary equity method investments are described below. In addition to recognition of our share of income from equity method investments, our equity method investments are evaluated for indicators of other-than-temporary impairment on an ongoing basis in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"). Other investments consist primarily of investments in cooperatives without readily determinable fair values and are generally measured at cost, unless an impairment or other observable market price change occurs, requiring an adjustment. CF Nitrogen We have a $2.7 billion investment in CF Industries Nitrogen, LLC ("CF Nitrogen"), a strategic venture with CF Industries Holdings, Inc. ("CF Industries"). The investment consists of an approximate 10% membership interest (based on product tons) in CF Nitrogen. We account for this investment using the hypothetical liquidation at book value method, recognizing our share of the earnings and losses of CF Nitrogen based upon our contractual claims on the entity's net assets pursuant to the liquidation provisions of the CF Nitrogen Limited Liability Company Agreement, adjusted for the semi-annual cash distributions we receive as a result of our membership interest in CF Nitrogen. For the three months ended May 31, 2020, and 2019, equity earnings were $41.3 million and $42.0 million, respectively. For the nine months ended May 31, 2020, and 2019, equity earnings were $104.0 million and $118.4 million, respectively. These amounts are included as equity income from investments in our Nitrogen Production segment. The following table provides summarized unaudited financial information for our equity method investment in CF Nitrogen for the nine months ended May 31, 2020, and 2019:
| Nine Months Ended May 31,
| 2020 |  | 2019
Net sales | $ | 1,954,660 |  |  | $ | 2,219,267 |
Gross profit | 481,711 |  |  | 560,631 |
Net earnings | 452,859 |  |  | 536,409 |
Earnings attributable to CHS Inc. | 104,021 |  |  | 118,415 |
Ventura Foods and Ardent Mills We have a 50% interest in Ventura Foods, LLC ("Ventura Foods"), which is a joint venture with Wilsey Foods, Inc., a majority-owned subsidiary of MK USA Holdings, Inc., that produces and distributes primarily vegetable-oil-based products. Additionally, we have a 12% interest in Ardent Mills, LLC ("Ardent Mills"), which is a joint venture with Cargill Incorporated and Conagra Brands, Inc., and combines the North American flour milling operations of the three parent companies. We account for Ventura Foods and Ardent Mills as equity method investments, and our share of the results of these equity methods investments are included in Corporate and Other. The following table provides aggregate summarized unaudited financial information for our equity method investments in Ventura Foods and Ardent Mills for the nine months ended May 31, 2020, and 2019:
| Nine Months Ended May 31,
| 2020 |  | 2019
Net sales | $ | 4,101,502 |  |  | $ | 4,427,127 |
Gross profit | 686,045 |  |  | 391,338 |
Net earnings | 134,774 |  |  | 152,315 |
Earnings attributable to CHS Inc. | 29,770 |  |  | 50,415 |
Our investments in other equity method investees are not significant in relation to our condensed consolidated financial statements, either individually or in the aggregate.

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for investments and other noncurrent assets. + References No definition available. + Details
Name: | us-gaap_InvestmentsAndOtherNoncurrentAssetsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration